Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

In the west of Kenya, near the shores of Lake Victoria, where I come from, a tuberculosis outbreak is no different from one that takes place anywhere else in the world. A few dozen people get sick, ...

The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding promises. It's a good economic investment, says the Fund's Peter Sands, into a ...

Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...

Texas Health Action CEO Christopher Hamilton stopped by KXAN to talk with anchor Will DuPree about how the prior authorization process can negatively impact the health of people living with HIV. Read ...

The US President's Emergency Plan for AIDS Relief has been a cornerstone of global HIV/AIDS prevention, care and treatment ...

The FDA has accepted under Priority Review the NDA for lenacapavir for the prevention of HIV as pre-exposure prophylaxis.

| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...

The U.S. government has ended funding for some 5,800 global health programs, cutting off critical support for projects ...

Arizona is seeing a surge in HIV cases and clinics that provide life-saving drugs and prevention services are worried they’re ...

A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten ...

Several protesters were arrested Wednesday after U.S. Agency for International Development workers were told via a text ...